Artoss Prospective Spine Registry Outcomes

Inclusion Criteria

• •Patient aged 18 years or older
• •Patient is diagnosed with a degenerative spine disorder requiring spinal fusion, has failed conservative treatment, and has decided to undergo surgery.
• •The surgeon has determined that a NanoBone product is or was clinically indicated, and will use or have used the product as a stand-alone bone graft substitute or in combination with local autograft only (no iliac crest harvesting, other BGS, or biologic {defined as containing growth factors, cytokines, proteins, or cells} used).
• •Patient capable of understanding the content of the Informed Consent Form
• •Patient willing and able to participate in the registry protocol including SOC follow-up visits and clinical evaluations.
• •Patient who has agreed to participate in the registry by providing consent according to the applicable local law and the Declaration of Helsinki.